NO164956C - Fremgangsmaate for fremstilling av en vannopploeselig farmasoeytisk akseptabel faststoff-dispersjon av klortalidon. - Google Patents

Fremgangsmaate for fremstilling av en vannopploeselig farmasoeytisk akseptabel faststoff-dispersjon av klortalidon.

Info

Publication number
NO164956C
NO164956C NO841010A NO841010A NO164956C NO 164956 C NO164956 C NO 164956C NO 841010 A NO841010 A NO 841010A NO 841010 A NO841010 A NO 841010A NO 164956 C NO164956 C NO 164956C
Authority
NO
Norway
Prior art keywords
water soluble
klortalidon
procedure
preparation
alkanol
Prior art date
Application number
NO841010A
Other languages
English (en)
Norwegian (no)
Other versions
NO164956B (no
NO841010L (no
Inventor
Nivedita Pandit
Stephen T Horhota
Original Assignee
Boehringer Ingelheim Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Ltd filed Critical Boehringer Ingelheim Ltd
Publication of NO841010L publication Critical patent/NO841010L/no
Publication of NO164956B publication Critical patent/NO164956B/no
Publication of NO164956C publication Critical patent/NO164956C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Dental Preparations (AREA)
  • Indole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO841010A 1983-03-16 1984-03-15 Fremgangsmaate for fremstilling av en vannopploeselig farmasoeytisk akseptabel faststoff-dispersjon av klortalidon. NO164956C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47589883A 1983-03-16 1983-03-16

Publications (3)

Publication Number Publication Date
NO841010L NO841010L (no) 1984-09-17
NO164956B NO164956B (no) 1990-08-27
NO164956C true NO164956C (no) 1990-12-05

Family

ID=23889624

Family Applications (1)

Application Number Title Priority Date Filing Date
NO841010A NO164956C (no) 1983-03-16 1984-03-15 Fremgangsmaate for fremstilling av en vannopploeselig farmasoeytisk akseptabel faststoff-dispersjon av klortalidon.

Country Status (20)

Country Link
EP (1) EP0125420B1 (es)
JP (1) JPS59176212A (es)
KR (1) KR880001755B1 (es)
AT (1) ATE31024T1 (es)
AU (1) AU562929B2 (es)
CA (1) CA1212329A (es)
DD (1) DD220225A5 (es)
DE (1) DE3467707D1 (es)
DK (1) DK162878C (es)
ES (1) ES8602633A1 (es)
FI (1) FI82188C (es)
GR (1) GR81478B (es)
HU (1) HU191596B (es)
IE (1) IE57031B1 (es)
IL (1) IL71248A (es)
NO (1) NO164956C (es)
NZ (1) NZ207514A (es)
PT (1) PT78259B (es)
YU (1) YU43349B (es)
ZA (1) ZA841916B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4933360A (en) * 1983-03-16 1990-06-12 Boehringer Ingelheim Pharmaceuticals, Inc. Novel chlorthalidone process and product
DE3612212A1 (de) * 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
WO1988000040A1 (en) * 1986-07-02 1988-01-14 American Health Products Corporation Topical hair growing composition and kit
US5955475A (en) * 1997-06-30 1999-09-21 Endo Pharmaceuticals Inc. Process for manufacturing paroxetine solid dispersions
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3055904A (en) * 1957-11-04 1962-09-25 Geigy Chem Corp New isoindoline derivatives
US4128632A (en) * 1978-02-13 1978-12-05 Merck & Co., Inc. Solubilization of Rafoxanide
US4285665A (en) * 1978-05-08 1981-08-25 Johnson, Matthey & Co., Limited Engines

Also Published As

Publication number Publication date
HUT34343A (en) 1985-03-28
DE3467707D1 (en) 1988-01-07
ZA841916B (en) 1985-11-27
FI82188C (fi) 1991-02-11
EP0125420B1 (en) 1987-11-25
IE840647L (en) 1984-09-16
FI841019A (fi) 1984-09-17
FI841019A0 (fi) 1984-03-14
DK162878C (da) 1992-05-18
EP0125420A2 (en) 1984-11-21
KR880001755B1 (ko) 1988-09-12
AU562929B2 (en) 1987-06-25
PT78259B (en) 1986-08-08
FI82188B (fi) 1990-10-31
ES530628A0 (es) 1985-12-01
DD220225A5 (de) 1985-03-27
DK162878B (da) 1991-12-23
DK156784A (da) 1984-09-17
AU2569684A (en) 1984-09-20
JPS59176212A (ja) 1984-10-05
KR840007874A (ko) 1984-12-11
YU43349B (en) 1989-06-30
IL71248A (en) 1987-02-27
IL71248A0 (en) 1984-06-29
IE57031B1 (en) 1992-03-25
DK156784D0 (da) 1984-03-15
ATE31024T1 (de) 1987-12-15
PT78259A (en) 1984-04-01
NZ207514A (en) 1987-02-20
EP0125420A3 (en) 1985-03-13
ES8602633A1 (es) 1985-12-01
HU191596B (en) 1987-03-30
YU45884A (en) 1987-06-30
NO164956B (no) 1990-08-27
GR81478B (es) 1984-12-11
NO841010L (no) 1984-09-17
CA1212329A (en) 1986-10-07

Similar Documents

Publication Publication Date Title
DK161744C (da) Fremgangsmaade til fremstilling af fritstroemmende ethylcellulosemikrokapsler
NO164956C (no) Fremgangsmaate for fremstilling av en vannopploeselig farmasoeytisk akseptabel faststoff-dispersjon av klortalidon.
JPS57192392A (en) Production of 3-alkoxymethylcephalosporin
FI813291L (fi) Fosfonmetylsubstituent innehaollande vattenloesliga cellulosablandetrar och foerfarande foer framstaellning av dem
JPS57203049A (en) Preparation of amide derivative
JPS5223018A (en) Process for preparation of acrylamide crystal
JPS5547651A (en) Production of sulfoxyimine
SE9400382L (sv) Förfarande för framställning av ett vattenlösligt komplex av vismut och en polyakrylsyra
JPS5569563A (en) Preparation of 2-methoxy-5-sulfamoylbenzoic acid amide
JPS5446779A (en) Preparation of 3-isoxazolylurea
JPS56120694A (en) Preparation of neocarzinostatin ma
JPS5564548A (en) Preparation of ester
JPS51133249A (en) A process for preparing alkyl-2,4- dichloro-nitrophenylcarbonates
JPS57185283A (en) Preparation of aminoalcohol derivative
JPS5551069A (en) Preparation of benzimidazole derivative
JPS5573643A (en) Preparation of fluoroalkylamides
JPS57130969A (en) Preparation of indole derivative
JPS5210291A (en) Process for preparing thienopyridine carboxylic acid derivatives